DI IASIO, Maria Grazia
 Distribuzione geografica
Continente #
NA - Nord America 3.285
AS - Asia 1.364
EU - Europa 788
SA - Sud America 261
AF - Africa 22
OC - Oceania 4
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.726
Nazione #
US - Stati Uniti d'America 3.243
SG - Singapore 556
CN - Cina 422
BR - Brasile 228
UA - Ucraina 183
DE - Germania 160
GB - Regno Unito 118
HK - Hong Kong 110
TR - Turchia 109
VN - Vietnam 89
IT - Italia 88
FI - Finlandia 61
SE - Svezia 53
RU - Federazione Russa 39
CA - Canada 19
MX - Messico 16
NL - Olanda 16
AR - Argentina 15
FR - Francia 15
IN - India 15
ID - Indonesia 14
BE - Belgio 13
PL - Polonia 13
BD - Bangladesh 10
JP - Giappone 9
ES - Italia 8
LT - Lituania 7
ZA - Sudafrica 7
PY - Paraguay 6
AU - Australia 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
IL - Israele 4
IR - Iran 4
MA - Marocco 4
SA - Arabia Saudita 4
CL - Cile 3
DZ - Algeria 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
CO - Colombia 2
HN - Honduras 2
IQ - Iraq 2
JO - Giordania 2
KE - Kenya 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AQ - Antartide 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
EE - Estonia 1
EG - Egitto 1
GI - Gibilterra 1
GR - Grecia 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MN - Mongolia 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.726
Città #
Fairfield 408
Woodbridge 385
Ashburn 326
Singapore 283
Houston 232
Jacksonville 199
Chandler 169
Beijing 151
Ann Arbor 140
Seattle 137
Santa Clara 127
Wilmington 122
Hong Kong 110
Cambridge 104
Izmir 66
New York 56
Dallas 50
Nanjing 47
Los Angeles 44
Munich 41
Ho Chi Minh City 40
Princeton 40
San Diego 39
Ferrara 32
Boardman 28
São Paulo 23
Shanghai 22
Hanoi 19
Brooklyn 18
Falls Church 18
Nanchang 16
Tianjin 16
Turku 16
Milan 15
Buffalo 14
Mexico City 14
Changsha 13
Brussels 12
Hefei 12
Montreal 12
Shenyang 12
Hebei 11
London 11
Poplar 11
San Mateo 11
Dearborn 10
Warsaw 10
Denver 9
Tokyo 9
Chicago 8
Helsinki 8
Atlanta 7
Columbus 7
Jakarta 7
Jiaxing 7
Norwalk 7
Orange 7
Zhengzhou 7
Ankara 6
Chennai 6
Council Bluffs 6
Dronten 6
Jinan 6
Stockholm 6
The Dalles 6
Verona 6
Washington 6
Auburn Hills 5
Augusta 5
Boston 5
Bremen 5
Kunming 5
Leawood 5
Manchester 5
Mountain View 5
Mumbai 5
Philadelphia 5
Porto Alegre 5
San Francisco 5
Belo Horizonte 4
Bologna 4
Brno 4
Guarulhos 4
Haiphong 4
Johannesburg 4
Orem 4
Ribeirão Preto 4
Amsterdam 3
Ardabil 3
Falkenstein 3
Frankfurt am Main 3
Goiânia 3
Haikou 3
Hải Dương 3
Monmouth Junction 3
Ningbo 3
Padova 3
Phoenix 3
Redondo Beach 3
São Gonçalo 3
Totale 3.960
Nome #
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 218
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 206
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 189
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 185
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 183
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 180
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 180
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 179
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 171
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 168
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 167
HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity 164
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 160
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 149
Reduced expression of cell cycle-associated genes in B lymphocytes purified from the peripheral blood of early-stage B chronic lymphocytic leukaemia patients 149
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 149
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 148
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 143
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 142
The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells 137
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 134
The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies 133
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 130
Exposure of B cell chronic lymphocytic leukemia (B-CLL) cells to Nutlin-3 induces a characteristic gene expression profile, which correlates with Nutlin-3-mediated cytotoxicity 128
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 127
Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region 127
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 126
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 121
Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women 102
null 100
null 98
null 98
null 97
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 91
Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias 91
null 89
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 84
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 84
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 83
null 83
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 78
null 69
Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes 68
null 55
Totale 5.763
Categoria #
all - tutte 25.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021310 0 0 0 0 0 51 18 54 10 59 89 29
2021/2022449 12 60 27 23 22 20 33 22 12 27 52 139
2022/2023398 41 20 20 41 66 57 11 32 54 7 28 21
2023/2024149 23 13 7 3 6 29 8 17 1 4 2 36
2024/2025895 23 21 64 44 122 50 44 38 187 65 135 102
2025/20261.335 259 172 208 314 348 34 0 0 0 0 0 0
Totale 5.763